谷歌浏览器插件
订阅小程序
在清言上使用

Updated Survival Results of BBCAPX-II: Sintilimab Combined with Bevacizumab and CapeOx As First-Line Treatment in Patients with RAS-mutant, Microsatellite Stable, Unresectable Metastatic Colorectal Cancer.

JOURNAL OF CLINICAL ONCOLOGY(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要